Wolverine Asset Management’s Sanofi SNY Stock Holding History

Wolverine Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-700	Closed	-$33.5K	–	2154
2014 Q4	$31K	Sell	700 -2,900	-81%	-$141K	﹤0.01%	1530
2014 Q3	$203K	Buy	3,600 +3,500	+3,500%	+$188K	﹤0.01%	1062
2014 Q2	$5K	Sell	100 -1,200	-92%	-$63.7K	﹤0.01%	2021
2014 Q1	$67K	Buy	+1,300	New	+$65.8K	﹤0.01%	1247

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wolverine Asset Management's SNY Position: Q1 2015 in Review

Wolverine Asset Management sold out of Sanofi (SNY) in Q1 2015, closing a stake of 700 shares — an estimated $33.5K sold.

Wolverine Asset Management first reported a position in SNY in Q1 2014 and held it in 4 quarters. The position peaked at $203K in Q3 2014. 518 funds tracked by Wall St. Rank hold SNY as of Q1 2015.

Wolverine Asset Management reported no remaining Sanofi position as of Q1 2015 after selling out during the quarter.
Wolverine Asset Management sold 700 Sanofi shares in Q1 2015, an estimated $33.5K.
Wolverine Asset Management first reported a position in Sanofi in Q1 2014 and held it in 4 quarters.
Wolverine Asset Management's Sanofi position peaked at $203K in Q3 2014.
518 funds tracked by Wall St. Rank held Sanofi as of Q1 2015.

Based on Wolverine Asset Management's 13F filing for Q1 2015, filed 15 May 2015.